Don’t want emails from us anymore? Click here to unsubscribe.

Good Afternoon! 

Hey, everyone. It's Adam from Elite Trade Club. Here’s what moved the market today.

AI & EV Supply Chain (Sponsored)

The World Is Racing for Critical Metals—This Company Could Be Leading the Charge

While the world focuses on the rise of EVs and AI, few are paying attention to the critical metals that make these innovations possible. Copper, nickel, and PGMs are essential components in batteries, data centers, and clean energy technologies—but global supply is struggling to keep up with soaring demand.

That’s where one Canadian mining company stands out. Their high-grade polymetallic discovery in Quebec has drawn comparisons to Russia’s famed Norilsk Mine, one of the richest metal deposits in the world.

With industry leaders Robert Friedland and Rob McEwen backing the project and a fully funded exploration program through 2025, this company could become a key player in supplying the metals driving the world’s most important industries.

Get the full report and company details here.

Markets 📈

The market saw life today despite tariff and inflation fears, leading to gains across several U.S. indexes. It was the Dow Jones that failed to impress, dropping nearly half a percent on the day.

Market-Moving News 📈

Retail

Target Bets Big on Apparel with New Champion Partnership

Target (NYSE: TGT) is stepping up its apparel game with an exclusive multiyear partnership with sportswear brand Champion. The retailer aims to strengthen its clothing category by introducing a new line of over 500 Champion-branded items, set to launch in August.

The collection, available in most Target stores and online, will feature a range of apparel for adults and kids, along with accessories, sporting goods, and bags. A special limited-time varsity-inspired collection will also roll out in September. Most items in the lineup will be priced under $40, keeping in line with Target’s affordability-focused strategy.

Target has a long history of leveraging brand partnerships to attract shoppers and differentiate itself in the competitive retail space. The company previously sold C9 by Champion for 15 years before replacing it with its private-label brand, All In Motion, in 2020. 

This new collaboration brings Champion back into Target’s stores with a more fashion-forward approach designed for style and everyday comfort.

The retailer has been focusing on apparel as a key growth driver, especially as shoppers remain selective with discretionary spending. Recent product launches, including exclusive collections, have shown strong consumer response, reinforcing Target’s strategy of combining well-known brands with value pricing.

With this partnership, Target is positioning itself to capture more customers looking for stylish yet affordable activewear, reinforcing its status as a go-to destination for everyday essentials and fashion.

Deliveries

Instacart Faces Investor Scrutiny as Revenue Falls Short

Instacart’s (NASDAQ: CART) latest earnings report did little to ease investor concerns, as revenue came in lower than expected despite increased order volume. The online grocery delivery platform has been investing heavily in making its services more accessible and affordable, but those efforts appear to be weighing on its margins.

The company reported higher gross transaction value, indicating strong demand, but revenue growth did not keep pace. Instacart attributed this to pricing adjustments and operational improvements to attract more customers. However, the market reacted negatively, lowering its stock in early trading.

This comes after a strong earnings report from competitor DoorDash recently surpassed expectations and provided an upbeat outlook. The contrast between the two companies has fueled debate over Instacart’s ability to sustain profitability while expanding its customer base.

Instacart has refined its pricing model and delivery efficiency, rolling out new features and partnerships to improve customer retention. While its leadership remains focused on long-term strategy, investors remain cautious about the financial impact of these initiatives.

With competition in the delivery space intensifying, the pressure is on Instacart to demonstrate that its approach can drive growth and profitability.

Insider Stock Alerts (Sponsored)

This Stock Alert Could Wake Up Your Portfolio

The market moves fast, and the biggest winners are those who spot the signals first.

While most investors are still asleep to what’s coming, these exclusive alerts deliver early insights on stocks primed for breakout moves.

(By clicking the link above, you agree to receive emails from GuyStocks. You can opt out at any time. - Privacy Policy)

Think of it as your personal stock alarm—ringing before the market takes off.

The best part? It’s 100% free. No gimmicks, no fees—just powerful stock alerts delivered straight to your inbox.

The next alert is about to go off—will you be ready?

Click here to get your first alert now.

(By clicking the link above, you agree to receive emails from GuyStocks. You can opt out at any time. - Privacy Policy)

Healthcare

Eli Lilly to Invest $27 Billion in U.S. Manufacturing Expansion

Eli Lilly has announced a major expansion plan, committing over $27 billion to build four new manufacturing plants in the U.S. This investment comes as the company experiences increased demand for its popular diabetes and weight loss drugs, as well as a growing pipeline of treatments for various conditions. The move also aligns with the broader trend of reshoring manufacturing to the U.S., a policy promoted by the current administration, which has encouraged companies to bring production back home to reduce reliance on foreign supply chains.

Eli Lilly’s new sites will focus on producing active ingredients for drugs like tirzepatide, the key compound in its weight loss drug Zepbound and diabetes treatment Mounjaro. This expansion is expected to address significant supply chain gaps in the U.S. and boost the company’s ability to meet the growing demand for these treatments. The investment also supports Eli Lilly’s efforts in other therapeutic areas, such as cancer and Alzheimer's disease.

The new manufacturing facilities will create more than 3,000 jobs in specialized fields like engineering and science, alongside 10,000 construction positions. While the specific locations for the new sites are yet to be determined, Eli Lilly’s latest investments bring its total U.S. manufacturing spend to over $50 billion in recent years, reflecting the company’s strong commitment to growth and innovation.

Technology (Sponsored)

Missed The Magnificent 7? Don’t Miss This

If you missed out on Apple, Tesla, or Amazon in their early days, you know how painful it is to watch those stocks skyrocket without you.

But here’s the good news—history is about to repeat itself.

We’ve identified 7 rapidly growing companies with the potential to become the next big market winners. These firms are innovating, expanding, and still flying under Wall Street’s radar—but not for long.

Get your FREE report: “The Next Magnificent 7 Stocks for 2025” right here.

Just like the original Magnificent Seven—Apple, Microsoft, Amazon, Alphabet, Nvidia, Meta, and Tesla—these companies are positioned for explosive growth. The key is getting in before the crowd.

Opportunities like this don’t last. Once the mainstream catches on, the biggest gains will be gone.

Click here to claim your free report and discover the next market leaders.

(By clicking the link above, you will get this free report and a free subscription to MarketBeat's daily email newsletter. You are also agreeing to the terms of our privacy policy. Unsubscribe at any time.)

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club